Co-Founder

Regulatory actions for Sept. 23, 2025

Bunkerhill Secures FDA Clearance for ECG-EF, Using AI to Detect Reduced Ejection Fraction from Routine ECGs

Bunkerhill Health Achieves FDA Clearance for Opportunistic Bone Density Assessment on Routine Abdominal CT

Other news to note for March 4, 2025

Sales Development Representative

Bunkerhill Health is innovating in the AI healthcare space by leveraging algorithms from top research institutions. They are seeking a Sales Development Representative to drive revenue growth through proactive outreach and relationship building with healthcare executives.

Sign up with Google

Sign in with Google